Pituitary metastasis: From pathology to clinical and radiological considerations

Purpose: A review of the literature with respect to pituitary metastases (PM) with clinical and radiological considerations are summarized to facilitate clinical decision making in the management of PM Methods: A review of literature associated with PM and tumour to tumour metastases in the English literature was reviewed and summarized Results: Pituitary metastases account for 1.0-3.6% of all surgically treated pituitary lesions. Often identified in parallel with extensive disseminated disease, once diagnosed, the prognosis is generally poor, although survival is highly heterogeneous and dependent on the primary tumor histology. Within this anatomical region is also the observation of tumor-to-tumor metastases and collision tumours. Both the tumor macro-and microenvironment play central roles to the progression of disease with distinctive radiological features that may suggest a metastatic sellar lesion as opposed to a primary pituitary lesion. Surgical resection is the first line of therapy followed by adjuvant chemoradiotherapy and endocrinological evaluation for hormonal supplementation Conclusion: PMs are relatively rare but important oncological entities representing disseminated disease in the majority of cases. Careful consideration of the relevant clinical history and radiological features can aid the clinician differentiate between a metastatic lesion to the pituitary region and a primary pituitary tumor. While surgical resection is first line therapy, stereotactic radiosurgery in carefully selected patients is emerging as a viable alternative. (c) 2021 Elsevier Ltd. All rights reserved.

Automated summary

Pituitary metastases are rare but important oncological entities, representing disseminated disease in most cases. Surgical resection is the preferred treatment, with stereotactic radiosurgery emerging as a viable alternative in carefully selected patients. Clinicians should differentiate between metastatic lesions to the pituitary region and primary pituitary tumors based on clinical history and radiological features.